Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017056 220017645 1.56 59.3 Not known (9) 2015-03-27 2015-03-28 AML MyeChild 01 IT Cyt null N 220028201 NOT MATCHED
220017057 220021508 1.83 75.5 Curative (C) 2015-09-27 2016-01-21 Cytarabine low (10to20mg/m2) IV/SC N N 220028201 CYTARABINE
220017058 220007321 null null Palliative (P) 2017-06-04 2017-10-22 CYTARABINE N N 220028203 CYTARABINE
220017059 220020855 1.04 null Disease modification (D) 2013-05-23 2013-05-31 null null null 220028207 NOT MATCHED
220017060 220007323 1.57 36.6 null 2015-05-04 2015-05-04 null 01 N 220028220 NOT MATCHED
220017061 220017649 null 43 Curative (C) 2017-10-20 2017-10-20 null null N 220028228 NOT MATCHED
220017062 220007325 1.81 28.5 Curative (C) 2017-04-25 2017-04-25 AML Relapsed FLA - DaunoXome null null 220028231 NOT MATCHED
220017063 220007327 1.78 88.7 Palliative (P) 2014-03-26 2014-03-27 Cytarabine Low Dose 2 N 220028245 CYTARABINE
220017064 220014038 0 10.6 Palliative (P) 2013-02-27 2013-03-19 Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE N N 220028246 NOT MATCHED
220017065 220007329 1.66 134 Not known (9) 2017-11-01 2017-11-01 Cytarabine Intrathecal (any age) Y N 220028248 CYTARABINE
220017066 220007330 1.6 48.5 null null 2017-10-04 Hydroxycarbamide N N 220028254 HYDROXYCARBAMIDE
220017067 220007334 1.63 null Curative (C) 2017-04-13 2017-04-14 AML Relapsed FLA - DaunoXome N N 220028284 NOT MATCHED
220017068 220007337 null 55.8 Disease modification (D) 2017-06-18 2017-11-21 FBC Conditionining N N 220028292 NOT MATCHED
220017069 220007341 0 0 null 2016-03-21 2017-03-16 Hydroxycarbamide Y N 220028304 HYDROXYCARBAMIDE
220017070 220007343 0 61.9 Disease modification (D) 2014-11-30 2014-12-02 AML Downs haM 01 N 220028308 NOT MATCHED
220017071 220007344 1.8 null Palliative (P) 2014-05-02 2014-05-03 Hydroxycarbamide 2 N 220028328 HYDROXYCARBAMIDE
220017072 220019682 1.57 61 Disease modification (D) 2018-07-28 2018-07-28 Hydroxycarbamide 2 N 220028337 HYDROXYCARBAMIDE
220017073 220007346 1.56 74 Disease modification (D) 2013-03-03 2013-07-10 FBC Conditionining N Y 220028341 NOT MATCHED
220017074 220014052 null 84.8 Disease modification (D) 2014-08-26 2014-12-31 Cytarabine Low Dose N null 220028347 CYTARABINE
220017075 220014052 null 75.4 Palliative (P) 2013-05-04 2013-10-13 CYTARABINE N N 220028347 CYTARABINE
220017076 220014052 1.62 0 Curative (C) 2015-04-26 2015-04-26 Hydroxycarbamide Y N 220028347 HYDROXYCARBAMIDE
220017077 220007351 0 null Curative (C) 2015-02-22 2015-02-22 null N N 220028359 NOT MATCHED
220017078 220007352 1.8 0 Palliative (P) 2015-02-19 2015-05-02 Hydroxycarbamide N null 220028370 HYDROXYCARBAMIDE
220017079 220007356 null 38.5 Disease modification (D) 2017-09-17 2017-09-22 AML Interim Guidelines FLA null N 220028384 NOT MATCHED
220017080 220007358 1.69 102 Palliative (P) 2018-11-12 2018-11-12 Cytarabine Low Dose N N 220028388 CYTARABINE
220017081 220017661 1.77 76.5 Disease modification (D) 2015-08-20 2015-11-24 CYTARABINE 02 N 220028388 CYTARABINE
220017082 220007361 1.67 60.799 Not known (9) null 2014-07-11 Hydroxycarbamide N null 220028396 HYDROXYCARBAMIDE
220017083 220014059 null 33.2 Curative (C) 2017-01-07 2017-01-07 AML Interim Guidelines N N 220028402 NOT MATCHED
220017084 220007365 1.6 33.5 Curative (C) 2014-01-08 2014-01-08 CYTARABINE 02 N 220028449 CYTARABINE
220017085 220007367 1.63 0 Curative (C) 2015-05-29 2015-06-02 Cytarabine Low Dose 2 N 220028452 CYTARABINE
220017086 220017666 null 85.2 Curative (C) 2014-07-30 2014-07-30 AML Downs haM null null 220028455 NOT MATCHED
220017087 220017666 0 96.7 Palliative (P) 2017-04-18 2017-04-18 Cytarabine Low Dose 01 N 220028455 CYTARABINE
220017088 220007371 1.67 14.3 Curative (C) 2014-12-13 2014-12-13 ETOPOSIDE + MITOXANTRONE N Y 220028466 NOT MATCHED
220017089 220014062 1.78 89.8 Disease modification (D) 2014-06-05 2014-06-05 Cytarabine low (10to20mg/m2) IV/SC N Y 220028467 CYTARABINE
220017090 220007372 1.04 null Disease modification (D) 2014-09-07 2014-09-22 Hydroxycarbamide null Y 220028469 HYDROXYCARBAMIDE
220017091 220014063 1.82 0 Curative (C) 2014-12-16 2015-06-04 Hydroxycarbamide 02 N 220028471 HYDROXYCARBAMIDE
220017092 220019691 null 55.5 Curative (C) 2015-04-28 2015-12-12 Cytarabine Low Dose N N 220028471 CYTARABINE
220017093 220007374 0 null Not known (9) 2016-03-12 2016-03-12 CYTARABINE N N 220028473 CYTARABINE
220017094 220007377 1.71 null Curative (C) 2018-06-30 2018-08-08 Cytarabine Low Dose 02 N 220028484 CYTARABINE
220017095 220014066 null 74.199 Disease modification (D) 2013-06-16 2013-07-22 null 2 N 220028490 NOT MATCHED
220017096 220007381 1.57 64.9 Curative (C) 2016-11-22 2017-01-04 AML MyeChild 01 FLA-Idarubicin N N 220028490 NOT MATCHED
220017097 220007383 1.77 82 Palliative (P) 2014-11-29 2014-12-04 Cytarabine Low Dose N N 220028504 CYTARABINE
220017098 220007387 null 92.9 Palliative (P) 2017-09-05 2017-09-12 Cytarabine Low Dose N N 220028506 CYTARABINE
220017100 220007389 1.67 51 Palliative (P) 2016-07-24 2016-07-29 Hydroxycarbamide N N 220028511 HYDROXYCARBAMIDE
220017101 220007390 null 57 Curative (C) 2014-12-18 2016-03-11 Cytarabine low (10to20mg/m2) IV/SC null N 220028517 CYTARABINE
220017102 220007390 1.78 73.5 Palliative (P) 2015-05-08 2015-05-08 Cytarabine Low Dose N N 220028517 CYTARABINE
220017103 220007393 null 70 Curative (C) null 2016-08-08 null 02 N 220028525 NOT MATCHED
220017104 220019694 0 null Palliative (P) 2018-07-06 2018-08-18 Hydroxycarbamide 2 N 220028533 HYDROXYCARBAMIDE
220017105 220007396 null 53 Curative (C) 2017-03-03 2017-05-29 Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE N N 220028542 NOT MATCHED
220017106 220007399 null 70.3 Palliative (P) null 2016-07-28 Cytarabine low (10to20mg/m2) IV/SC N N 220028542 CYTARABINE